首页> 外文期刊>Genetic Engineering & Biotechnology News: The Information Source of the Biotechnology Industry >Ion Channels Open Doors to New Drugs: Increased R&D Efforts Are Overcoming Obstacles and Showing Potential
【24h】

Ion Channels Open Doors to New Drugs: Increased R&D Efforts Are Overcoming Obstacles and Showing Potential

机译:离子通道为新药敞开大门:加大研发力度克服障碍并显示出潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Ion channels make good drug targets— they reside on the cell surface and are s% fast switching mechanisms. They act like cell transistors, controlling many cell processes. There are close to 500 types of ion channels, yet many remain undiscovered. This was mainly attributed to technology restraints, however, with the recent introduction of HT patch clamping, as well as new assays that facilitate faster, more robust screening, there are more ion channel receptors being detected. Researchers at the recent Society for Biomolecular Screening conference and CHI's upcoming "Pharmacology Driven Assays for GPCRs and Ion Channels" shared information on a cornucopia of topics, including the latest enabling technologies, new screening paradigms, and novel approaches to generate GPCRs.
机译:离子通道可作为良好的药物靶标,它们位于细胞表面,是快速切换的机制。它们就像单元晶体管一样,控制着许多单元过程。离子通道类型接近500种,但仍有许多未被发现。这主要归因于技术限制,但是,随着最近HT膜片钳的引入,以及有助于更快,更可靠筛查的新检测方法,检测到了更多的离子通道受体。在最近的生物分子筛选学会会议和CHI即将进行的“药理学驱动的GPCR和离子通道的测定”研究中,研究人员分享了有关聚宝盆的信息,包括最新的启用技术,新的筛选范例以及生成GPCR的新颖方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号